Overview

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2028-12-01

Target enrollment:

Participant gender:

Summary

A study of adebelimab in combination with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer

Phase:

PHASE2

Details

Lead Sponsor:

Fujian Cancer Hospital